Multicomponent filling and sterilizing systems represent unique advantages for vaccine production. With appropriate changes to process parameters, blow/fill/seal (BFS) systems can be adapted for vaccine production without incurring any product degradation.
While COVID-19’s influence persists, we see renewed interest in sustainability and the evolving impact of Brexit’s export regulations, which will shape how the pharma and cold chain industries operate.
Just-in-time monitoring can offer companies a reliable, cost-effective means of tracking a shipment’s temperature fluctuations in transit, allowing for usable regulatory data that can inform subsequent shipping strategy.
High Voltage Leak Detection (HVLD) is a technology first applied to pharma manufacturing in the 1970s. In this article you will learn more about other packaging applications that can be inspected with HVLD.
Understand how the streamlining of processes and harmonization of products and services can better serve pharmaceutical companies. A case study highlights how a unique combination of expertise in automation and glass primary packaging benefited a pharmaceutical giant.
Read about a combination of innovative technologies that can substantially reduce the fill/finish manufacturing bottleneck with ultra-high-speed filling lines that are enabled by next-generation pharmaceutical glass packaging.
Our fully contained and integrated OPTIMA line utilizes scan isolated barrier technology to ensure the required sterility for fill finish while offering flexibility to meet your cGMP, clinical, and commercial drug product manufacturing needs.